About H.I.G. BioHealth

We invest in companies developing novel products for significant unmet medical needs, primarily in the following sectors:

  • Therapeutics (small molecules, protein therapeutics, antibodies, etc.)
  • Medical devices
  • Diagnostics

After making an investment, the H.I.G. BioHealth Partners team works closely with portfolio companies in key areas, including:

  • Pre-clinical and clinical development strategy
  • Management recruitment
  • Business development activities
  • Follow on equity and debt financing
  • Achieving liquidity through M&A or IPO